Trillium Therapeutics Inc

Trillium Therapeutics Inc. is a clinical stage immuno-oncology company. The Company develops therapies for the treatment of cancer and has preclinical programs, targeting the immunoregulatory pathways that tumor cells exploit to evade the host immune system.